# Innovative approach to recurrent giant cell tumor of the hand: free osteoarticular metatarsal transfer with simplified donor site management

## TL;DR

A new surgical method using a metatarsal bone graft successfully treats a recurring hand tumor with minimal complications and good recovery.

## Contribution

A simplified donor site management technique for free osteoarticular metatarsal grafts in recurrent giant cell tumor treatment.

## Key findings

- The patient had excellent functional outcomes with a stable joint and active range of motion after 2 years.
- Radiographs showed successful graft incorporation and preserved joint space with no donor site complications.
- Simplified donor site management reduced surgical complexity without compromising results.

## Abstract

A 36-year-old female with recurrent giant cell tumor (GCT) of the left fifth metacarpal was treated with en bloc resection and free osteoarticular metatarsal graft from the fourth metatarsal. Donor site management involved primary closure without bone reconstruction. The patient experienced excellent functional outcomes at 2-year follow-up, with a stable metacarpophalangeal joint and an active range of motion of 0–80 deg. No donor site complications were reported, and radiographs demonstrated successful graft incorporation and preserved joint space. The simplified donor site management reduced surgical complexity without compromising outcomes. Free osteoarticular metatarsal graft of the fourth metatarsal offers a function-preserving option for managing recurrent GCT of the hand, with minimal morbidity and durable results.